Allogene Therapeutics (ALLO) Capital Expenditures (2018 - 2026)
Allogene Therapeutics (ALLO) posted Capital Expenditures of $150,000 for Q2 2026, up 240.9% from $44,000 a year earlier.
Powered by 
Analysis
Allogene Therapeutics (ALLO) Capital Expenditures (2018 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Capital Expenditures at Allogene Therapeutics was $402,000, down 51.5% year-over-year; for FY2025, it was $386,000, down 44.4% from FY2024.
- Annual Capital Expenditures has declined for five consecutive years, with a five-year compound annual growth rate of -64.2% (FY2020 to FY2025).
- In prior years, Allogene Therapeutics' Capital Expenditures was $694,000 in FY2024 (-54.2%), $1.52 million in FY2023 (-70.8%), $5.19 million in FY2022 (-75.8%) and $21.45 million in FY2021 (-67.5%).
- Quarterly Capital Expenditures has run from a low of $8,000 in Q1 2024 to a high of $3.35 million in Q3 2021 over five years.
- On a year-over-year basis, Capital Expenditures increased in two of the last four quarters, with growth averaging 37.2%.
- The strongest year-over-year quarter for Capital Expenditures in the past five years was Q2 2026, with growth of 240.9%; the weakest was Q1 2024, with a decline of 99.2%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 3.18 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 301.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.04 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -3.30 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 587.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 237.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 573.00 Mn |
| 10 | Allogene Therapeutics | 322.04 Mn | -820.62 Mn | - | 3.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 3.32 Mn |
| Jun 30, 2026 | 3.45 Mn |
| Mar 31, 2026 | 3.24 Mn |
| Dec 31, 2025 | 3.24 Mn |
| Sep 30, 2025 | 3.41 Mn |
| Jun 30, 2025 | 3.34 Mn |
| Mar 31, 2025 | 3.33 Mn |
| Mar 31, 2024 | 3.08 Mn |
| Dec 31, 2023 | 3.22 Mn |
| Sep 30, 2023 | 3.04 Mn |
| Jun 30, 2023 | 3.31 Mn |
| Mar 31, 2023 | 4.00 Mn |
| Dec 31, 2022 | 4.63 Mn |
| Sep 30, 2022 | 2.85 Mn |
| Jun 30, 2022 | 3.38 Mn |
| Mar 31, 2022 | 3.88 Mn |
| Dec 31, 2021 | 2.69 Mn |
| Sep 30, 2021 | 4.97 Mn |
| Jun 30, 2021 | 12.37 Mn |
| Mar 31, 2021 | 7.43 Mn |
API Access
Allogene Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ALLO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "ALLO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ALLO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();